| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $0.536 (Beat by $0.086) |
| EPS GAAP Actual | $0.536 (Beat by $0.086) |
| Revenue Actual | $6.404B |
| Revenue Surprise | Beat by $6404M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.68706 |
| EPS GAAP Estimate | $0.68706 |
| Revenue Estimate | $6.04096385B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 2.96939 | 8.45 | 2.92998 | 3.0555 | 1 |
| Dec 2027 | 2.38925 | 10.5 | 2.35874 | 2.43357 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.66 | 0.11043 | 6.404B | -0.28% | 55.78M |
| FQ3 2025 (Sep 2025) | 4.83 | 4.20496 | 6.049B | 1.29% | -11751.75M |
| FQ2 2025 (Jun 2025) | 0.63 | 0.01306 | 6.085B | 1.31% | -10097.5M |
| FQ1 2025 (Mar 2025) | 0.68 | 0.16891 | 5.93B | -1.37% | 56.83M |
| FQ4 2024 (Dec 2024) | 0.51 | -0.01482 | 6.422B | -0.79% | 130.55M |
| FQ3 2024 (Sep 2024) | -1.36 | -2.90141 | 5.971B | -1.83% | -6189M |
| FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 6.005B | -1.02% | 6005M |
| FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 6.011B | -0.72% | 6011M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.68706
Consensus Revenue Estimates
6.04096385B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.71623 | -- | 0.68491 | 0.7471 | 1 |
| FQ3 2027 (Sep 2027) | 0.80201 | -- | 0.80201 | 0.80201 | 8 |
| FQ2 2027 (Jun 2027) | 0.74925 | -- | 0.74925 | 0.74925 | 5 |
| FQ1 2027 (Mar 2027) | 0.64357 | -- | 0.61543 | 0.67131 | 1 |
| FQ4 2026 (Dec 2026) | 0.70698 | 6.65 | 0.69745 | 0.72183 | 1 |
| FQ3 2026 (Sep 2026) | 0.77668 | -521.88 | 0.76621 | 0.79299 | 1 |
| FQ2 2026 (Jun 2026) | 0.76672 | 17.83 | 0.75638 | 0.78282 | 1 |
| FQ1 2026 (Mar 2026) | 0.68706 | 1.03 | 0.6778 | 0.70149 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.34B | -- | 6.12B | 6.55B | 3 |
| FQ3 2027 (Sep 2027) | 6.18B | -- | 6.18B | 6.18B | 4 |
| FQ2 2027 (Jun 2027) | 6.15B | -- | 6.15B | 6.15B | 6 |
| FQ1 2027 (Mar 2027) | 6.26B | -- | 6.05B | 6.47B | 3 |
| FQ4 2026 (Dec 2026) | 6.08B | -5.39 | 6.01B | 6.17B | 1 |
| FQ3 2026 (Sep 2026) | 6.06B | 0.26 | 6B | 6.16B | 1 |
| FQ2 2026 (Jun 2026) | 6.05B | -0.53 | 5.99B | 6.15B | 1 |
| FQ1 2026 (Mar 2026) | 6.04B | 1.84 | 5.98B | 6.14B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.54957 | 0.66 | 0.11043 | 16.73% |
| FQ3 2025 (Sep 2025) | 0.62504 | 4.83 | 4.20496 | 87.06% |
| FQ2 2025 (Jun 2025) | 0.61694 | 0.63 | 0.01306 | 2.07% |
| FQ1 2025 (Mar 2025) | 0.51109 | 0.68 | 0.16891 | 24.84% |
| FQ4 2024 (Dec 2024) | 0.52482 | 0.51 | -0.01482 | -2.91% |
| FQ3 2024 (Sep 2024) | 1.54141 | -1.36 | -2.90141 | 213.34% |
| FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 100% | |
| FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $6.35B | $6.4B | $55.78M | 0.87% |
| FQ3 2025 (Sep 2025) | $17.8B | $6.05B | $-11751.75M | -194.28% |
| FQ2 2025 (Jun 2025) | $16.18B | $6.09B | $-10097.5M | -165.94% |
| FQ1 2025 (Mar 2025) | $5.87B | $5.93B | $56.83M | 0.96% |
| FQ4 2024 (Dec 2024) | $6.29B | $6.42B | $130.55M | 2.03% |
| FQ3 2024 (Sep 2024) | $12.16B | $5.97B | $-6189M | -103.65% |
| FQ2 2024 (Jun 2024) | $0B | $6.01B | $6005M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $6.01B | $6011M | 100% |